LeonaBio Insider Trades
NASDAQ: LONAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 10 · $99.42K
- Shares bought / sold
- 0 / 16.75K
- Net activity
- Net selling $99,418
LeonaBio insider activity
Over the last 12 months, LeonaBio insiders reported 22 transactions on SEC Form 4: 0 open-market purchases and 10 sales. Insiders bought $0 and sold $99,418 worth of stock, for net insider selling of $99,418. The largest seller was Litton Mark James, with $45,479 in reported sales.
The most recent filing shows CHURCH KEVIN (CHIEF SCIENTIFIC OFFICER) selling 1,359 shares at $5.37 on Mar 4, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put LONA's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
LONA insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Mar 4, 2026 | San Martin JavierCHIEF MEDICAL OFFICER | Sale | 1,720 | $9.24K | Form 4 |
| Mar 4, 2026 | Worthington MarkGENERAL COUNSEL and CCO | Sale | 1,328 | $7.13K | Form 4 |
| Mar 4, 2026 | Renninger RobertCHIEF FINANCIAL OFFICER | Sale | 906 | $4.87K | Form 4 |
| Mar 4, 2026 | Litton Mark JamesPRESIDENT and CEO | Sale | 5,156 | $27.69K | Form 4 |
| Mar 4, 2026 | CHURCH KEVINCHIEF SCIENTIFIC OFFICER | Sale | 1,359 | $7.30K | Form 4 |
| Mar 3, 2026 | San Martin JavierCHIEF MEDICAL OFFICER | Option exercise | 7,418 | — | Form 4 |
| Mar 3, 2026 | Worthington MarkGENERAL COUNSEL and CCO | Option exercise | 5,726 | — | Form 4 |
| Mar 3, 2026 | Renninger RobertCHIEF FINANCIAL OFFICER | Option exercise | 3,900 | — | Form 4 |
| Mar 3, 2026 | Litton Mark JamesPRESIDENT and CEO | Option exercise | 22,254 | — | Form 4 |
| Mar 3, 2026 | CHURCH KEVINCHIEF SCIENTIFIC OFFICER | Option exercise | 5,856 | — | Form 4 |
| Jan 2, 2026 | Worthington MarkGeneral Counsel and CCO | Sale | 876 | $6.03K | Form 4 |
| Jan 2, 2026 | Renninger RobertChief Financial Officer | Sale | 297 | $2.04K | Form 4 |
| Jan 2, 2026 | CHURCH KEVINCHIEF SCIENTIFIC OFFICER | Sale | 876 | $6.03K | Form 4 |
| Jan 2, 2026 | Litton Mark JamesPresident and CEO | Sale | 2,586 | $17.79K | Form 4 |
| Jan 2, 2026 | San Martin JavierCHIEF MEDICAL OFFICER | Sale | 1,644 | $11.31K | Form 4 |
| Dec 31, 2025 | Worthington MarkGeneral Counsel and CCO | Option exercise | 3,667 | — | Form 4 |
| Dec 31, 2025 | Renninger RobertChief Financial Officer | Option exercise | 1,236 | — | Form 4 |
| Dec 31, 2025 | CHURCH KEVINCHIEF SCIENTIFIC OFFICER | Option exercise | 3,667 | — | Form 4 |
| Dec 31, 2025 | Litton Mark JamesPresident and CEO | Option exercise | 10,834 | — | Form 4 |
| Dec 31, 2025 | San Martin JavierCHIEF MEDICAL OFFICER | Option exercise | 4,667 | — | Form 4 |
| Nov 18, 2025 | Renninger RobertChief Financial Officer | Award | 1,000 | $2.31K | Form 4 |
| Nov 18, 2025 | CHURCH KEVINCHIEF SCIENTIFIC OFFICER | Award | 1,000 | $2.31K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4